First Trust Nasdaq Pharmaceuticals ETF Rating $25.79 +0.09 (+0.33%) As of 11:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.61Holdings in FTXH have an aggregate rating of Moderate Buy based on 758 analyst ratings issued in the past year covering 50 companies (99.9% of the portfolio).FTXH Aggregate Price Target$25.80High Prediction$25.80Average Prediction$25.80Low Prediction$25.80Holdings in FTXH have an aggregate price target of $25.80 and a range of $25.80 to $25.80 covering 50 companies (99.9% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.72%JNJJohnson & Johnson$156.32+0.3%4.6276 of 5 stars2.63$171.82 9.9%197.11%MRKMerck & Co., Inc.$85.23+0.6%5 of 5 stars2.59$111.13 30.4%22Earnings ReportInsider Trade7.09%ABBVAbbVie$195.15+0.8%4.8364 of 5 stars2.89$211.41 8.3%27Earnings ReportAnalyst ForecastAnalyst Revision7.08%PFEPfizer$24.41+2.6%4.9688 of 5 stars2.53$29.64 21.4%17Earnings ReportDividend AnnouncementAnalyst Forecast6.71%BMYBristol-Myers Squibb$50.21+2.0%4.5623 of 5 stars2.32$58.00 15.5%22Earnings ReportInsider TradeAnalyst Revision3.84%LLYEli Lilly and Company$899.78+1.6%4.91 of 5 stars2.80$1,000.32 11.2%20Upcoming EarningsAnalyst Downgrade3.82%GILDGilead Sciences$106.54+2.2%4.6948 of 5 stars2.78$109.43 2.7%27Earnings ReportDividend AnnouncementAnalyst Revision3.81%UTHRUnited Therapeutics$303.09+0.8%4.9001 of 5 stars2.67$390.17 28.7%12Earnings ReportAnalyst RevisionNews CoveragePositive NewsGap Up3.74%ZTSZoetis$156.65+0.8%4.4987 of 5 stars3.08$214.40 36.9%12Upcoming EarningsOptions VolumePositive News3.73%AMGNAmgen$290.92+0.8%4.0615 of 5 stars2.43$310.57 6.8%23Upcoming EarningsPositive News3.58%VTRSViatris$8.42+1.0%1.8463 of 5 stars1.75$10.50 24.7%43.53%REGNRegeneron Pharmaceuticals$598.76+5.2%4.823 of 5 stars2.88$912.20 52.3%26Earnings ReportAnalyst Forecast3.50%BIIBBiogen$121.08+0.8%4.6849 of 5 stars2.38$201.93 66.8%32Upcoming EarningsAnalyst DowngradeAnalyst Revision3.12%JAZZJazz Pharmaceuticals$116.96+0.5%4.8293 of 5 stars2.93$187.71 60.5%14Upcoming EarningsAnalyst RevisionNews CoveragePositive News2.42%OGNOrganon & Co.$12.94-1.7%4.7571 of 5 stars2.33$19.75 52.6%6Upcoming EarningsPositive News2.09%EXELExelixis$39.15+1.6%3.9751 of 5 stars2.50$37.59 -4.0%20Short Interest ↑Analyst RevisionPositive News1.89%MEDPMedpace$308.39+0.7%4.3477 of 5 stars2.23$349.30 13.3%13Insider TradeShort Interest ↑1.67%ILMNIllumina$77.60+0.6%4.6366 of 5 stars2.48$137.55 77.3%21Analyst ForecastPositive News1.65%CRLCharles River Laboratories International$118.48+1.0%4.8194 of 5 stars1.94$182.00 53.6%16Upcoming EarningsPositive News1.59%ELANElanco Animal Health$9.48-2.7%3.9122 of 5 stars2.43$14.67 54.7%7Upcoming EarningsShort Interest ↑News Coverage1.55%HALOHalozyme Therapeutics$61.42+1.0%3.9945 of 5 stars2.60$62.89 2.4%10Upcoming EarningsInsider TradeAnalyst Revision1.37%NBIXNeurocrine Biosciences$107.69+0.4%4.8541 of 5 stars2.86$160.90 49.4%22Upcoming EarningsAnalyst ForecastAnalyst Revision1.27%BMRNBioMarin Pharmaceutical$63.69+0.6%4.9164 of 5 stars2.70$93.14 46.2%23Upcoming EarningsPositive News1.01%ALKSAlkermes$28.774.6092 of 5 stars2.58$38.08 32.4%12Upcoming EarningsAnalyst ForecastPositive News0.93%PRGOPerrigo$25.74+0.5%4.8505 of 5 stars2.25$33.00 28.2%4Upcoming EarningsDividend AnnouncementShort Interest ↑Positive News0.81%AMRXAmneal Pharmaceuticals$7.66-1.2%3.3503 of 5 stars3.00$10.80 41.0%5Positive News0.80%PBHPrestige Consumer Healthcare$81.05-1.1%4.1436 of 5 stars2.50$93.33 15.2%6Analyst UpgradePositive News0.78%CPRXCatalyst Pharmaceuticals$24.29+0.0%4.6813 of 5 stars3.13$32.29 32.9%8Upcoming EarningsNews CoveragePositive News0.77%ADMAADMA Biologics$23.80-1.3%1.487 of 5 stars3.25$22.50 -5.5%4News CoveragePositive NewsGap Down0.76%TGTXTG Therapeutics$45.51+3.8%3.3182 of 5 stars2.83$40.67 -10.6%6Upcoming EarningsNews CoveragePositive NewsGap Down0.67%CORTCorcept Therapeutics$71.88-1.8%4.8138 of 5 stars3.00$143.25 99.3%5Upcoming EarningsShort Interest ↓Positive News0.63%GHGuardant Health$47.23-4.6%3.932 of 5 stars3.05$49.00 3.7%21Gap Down0.59%CAHCardinal Health$141.25+1.0%4.4156 of 5 stars2.71$142.36 0.8%14Upcoming EarningsAnalyst ForecastShort Interest ↑Positive News0.58%VRTXVertex Pharmaceuticals$509.50+1.2%3.9194 of 5 stars2.64$514.91 1.1%25Upcoming EarningsAnalyst RevisionPositive News0.56%ALNYAlnylam Pharmaceuticals$263.24+2.4%4.2995 of 5 stars2.77$315.58 19.9%26Upcoming EarningsAnalyst DowngradePositive News0.54%EXASExact Sciences$45.64+1.9%4.3873 of 5 stars2.95$69.25 51.7%22Upcoming EarningsPositive News0.53%MDGLMadrigal Pharmaceuticals$333.91-2.0%3.7273 of 5 stars3.00$409.00 22.5%9Upcoming EarningsNews CoveragePositive News0.53%KRYSKrystal Biotech$169.88-0.4%4.898 of 5 stars3.00$222.71 31.1%8Upcoming EarningsAnalyst ForecastNews CoveragePositive News0.52%VCYTVeracyte$30.50-2.8%3.9476 of 5 stars2.70$42.60 39.7%10Upcoming EarningsShort Interest ↑Gap Down0.51%PTCTPTC Therapeutics$49.84+0.6%4.0543 of 5 stars2.53$63.92 28.3%15Upcoming EarningsPositive News0.50%BPMCBlueprint Medicines$89.50+1.2%2.5549 of 5 stars2.68$124.53 39.1%22Upcoming EarningsAnalyst ForecastPositive News0.50%SRRKScholar Rock$32.91+0.4%4.0415 of 5 stars3.00$42.67 29.6%6Upcoming EarningsInsider TradeNews CoveragePositive News0.48%INSMInsmed$72.00+0.8%4.3337 of 5 stars3.00$94.00 30.6%16Positive News0.47%AXSMAxsome Therapeutics$112.29+2.2%4.8237 of 5 stars3.00$169.87 51.3%16Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News0.47%AKROAkero Therapeutics$45.61+6.0%3.7677 of 5 stars3.00$76.29 67.3%9Insider TradeNews CoveragePositive News0.45%INCYIncyte$62.66+3.7%4.704 of 5 stars2.21$73.94 18.0%19Earnings ReportAnalyst ForecastNews Coverage0.45%VCELVericel$38.02-3.4%2.2971 of 5 stars3.00$60.86 60.1%7Positive News0.44%SWTXSpringWorks Therapeutics$46.30+0.1%1.9571 of 5 stars2.13$52.57 13.5%8Upcoming EarningsAnalyst ForecastNews CoverageHigh Trading Volume0.43%ACADACADIA Pharmaceuticals$14.60+1.2%4.248 of 5 stars2.50$23.87 63.5%160.33%SRPTSarepta Therapeutics$62.40+2.5%4.7287 of 5 stars2.83$158.70 154.3%24 This page (NASDAQ:FTXH) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FTXH Stock Free FTXH Stock Alerts